development preventive vaccine ebola virus infection primates 
outbreaks haemorrhagic fever caused ebola virus associated high mortality rates distinguishing feature human pathogen highest lethality associated zaire subtype one four strains identified date12 rapid progression allows little opportunity develop natural immunity currently effective anti-viral therapy therefore vaccination offers promising intervention prevent infection limit spread describe highly effective vaccine strategy ebola virus infection non-human primates combination dna immunization boosting adenoviral vectors encode viral proteins generated cellular humoral immunity cynomolgus macaques challenge lethal dose highly pathogenic wild-type mayinga strain ebola zaire virus resulted uniform infection controls progressed moribund state death less one week contrast vaccinated animals asymptomatic six months detectable virus initial challenge findings demonstrate possible develop preventive vaccine ebola virus infection primates 
